Skip to main content
Equibles
APVO logo

APVO · Aptevo Therapeutics Inc. · Suppliers & Customers

Track APVO — free

Use APVO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research APVO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.37 +0.01 (+0.74%) At close · Nov 4
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.47M
Shares
1.80M
Volume · Nov 4 14.78K Avg daily vol (3M) 95.88K

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones APVO names, and the companies that name APVO.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who APVO sells to, buys from, competes and partners with

  • 1 supplier
  • 0 customers
  • 39 competitors
  • 1 partner

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1671584 CUSIP 03835L702 13F (30d) 2 filings 2 filers Visit website Investor relations